Photo via NPR

This woman defied lethal cancer. Can mRNA vaccines make that possible for others?

Read the original at NPR ↗
Cite

Noguchi, Y. (2026, November 2). This woman defied lethal cancer. Can mRNA vaccines make that possible for others? NPR. https://www.npr.org/2026/11/02/nx-s1-6009085/mrna-cancer-vaccine-pancreatic-skin

Dated from the outlet's own feed. Check the original for its byline.

NPR · collected 2026-11-03 · by Yuki Noguchi

Quick Summary

Donna Gustafson, a 72-year-old former accountant from New Jersey who was diagnosed with Stage II pancreatic cancer seven years ago, has become one of the world's first recipients of an mRNA vaccine designed to treat her disease. After receiving nine doses of the vaccine along with surgery and chemotherapy as part of a small clinical trial involving 16 patients at Memorial Sloan Kettering Cancer Center in New York City, Gustafson is now cancer-free and living a normal life. The trial showed positive results for half of the participants; seven out of eight patients who responded to the treatment are still alive today. The article discusses how mRNA vaccines, combined with advances in genomics and AI, could potentially offer new hope against highly lethal cancers like pancreatic cancer, though researchers do not yet fully understand why some trials succeed while others fail.
Written by AI on 2026-11-03, from this article's own text only (the story summary below draws on all the coverage).

AI analysis

Story summary

Donna Gustafson, a 72-year-old retired accountant from Florida, has remarkably survived Stage II pancreatic cancer since receiving the world’s first personalized mRNA vaccine seven years ago. Despite being diagnosed with a highly lethal form of cancer that affects about 70,000 Americans annually, she remains healthy and active, experiencing no recurrence or side effects. Gustafson's treatment involved an innovative approach where her tumor samples were used to create a customized vaccine aimed at reprogramming her immune cells to combat cancerous cells.

The success of this personalized mRNA therapy is part of a broader trend in cancer treatment, following recent promising results from trials conducted by pharmaceutical companies Moderna and Merck, which showed a 42% reduction in recurrence and death over two years for skin cancer patients. This breakthrough highlights the potential of mRNA vaccines to transform cancer care and offers hope to those facing similar diagnoses.

Written for “mRNA Vaccines Potential Against Cancer” on 2026-11-03, grounded in this article and the 0 other(s) covering the same event.
Why this leaning score
This article does not take a side on a contested political question, so it has no leaning score. That is an answer rather than a gap: a match report or a rescue can be warmly or critically written without being left or right, and scoring it anyway is how approval of a subject gets recorded as a political position.
No political leaning scored for article 125310 · logged 2026-11-03

Story

📰 mRNA Vaccines Potential Against Cancer
Health · 1 article(s) covering the same event.

Compared with similar articles

Nothing to compare against. No article is close enough to this one for the pipeline to have linked or judged the pair.
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
39
sentences that state something as happening or true
Uncertain
3%
1 of 39 hedged ("reportedly", "may", "according to")
Leaning
not political
takes no side on a contested political question
Publisher signals
60/100
NPR's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
1
Health
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-11-03 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

NPR · 1035 article(s) · 3 correction(s) detected
Running correction rate · 3 correction(s)

Who wrote this

Yuki Noguchi
3 article(s) here · 1 carrying a prediction
🔮 "I had no symptoms, no side effects — to the point where I was actually worried that maybe it was not helping.
🔮 That winter, on New Year's Eve, Engel woke up feeling as if a patch covered his right eye: "I couldn't see anything.
🔮 "Super ironic that I would be co-leading the center that supports research and education in this disease, and I get diagnosed myself," he says.
Also by Yuki Noguchi
Nothing else under this byline is closely related to this article, so these are simply their most recent.

Topics

Americans Florida Merck Moderna New Jersey

Subjects

Gustafson PERSON · 6× Balachandran PERSON · 4× Donna Gustafson PERSON · 2× Americans NORP · 1× Ed Gustafson PERSON · 1× Florida GPE · 1× Merck ORG · 1× Moderna ORG · 1× New Jersey GPE · 1× Vinod Balachandran PERSON · 1×

Narrative

mRNA vaccines having a moment It's been a big year for cancer vaccines using mRNA, especially after drugmakers Merck and Moderna released results last month from the first major successful trial of mRNA vaccines for skin cancer, showing a 42% reduction in recurrence and death over two years.
framing: assertive · carried by 1 article(s) · first seen 2026-11-03
🔮 "I had no symptoms, no side effects — to the point where I was actually worried that maybe it was not helping.

Claims (39 extracted, 1 hedged)

This woman defied lethal cancer. asserted
woman → defy → cancer
Can mRNA vaccines make that possible for others? asserted
that → make → others
Donna Gustafson is living a cancer patient's fantasy. asserted
Gustafson → live → fantasy
At 72, the retired accountant hikes, travels, lifts weights, and exchanges adoring glances with Ed, the husband she married 50 years ago. asserted
she → hike → Ed
All these moments are happening while she shows zero evidence of the Stage II pancreatic cancer that was supposed to kill her years ago. asserted
that → happen → her
"I have had 100% quality of life; I am back to where I was prior," Gustafson says. asserted
Gustafson → have → life
"She's better than that," her husband interjects. asserted
husband → interject → that
"She's sassier, and she's in the best shape of her life — there's no question about that." asserted
she → be → that
Seven years ago, Gustafson became the world's first recipient of an mRNA vaccine designed to treat pancreatic cancer, a highly lethal disease diagnosed in about 70,000 Americans every year. asserted
Gustafson → become → Americans
There are few effective treatments for the disease, but Gustafson's was a personalized version, created using samples of her tumor, aiming to reprogram her immune cells — training them, essentially, to recognize distinctive mutant proteins on cancerous cells and kill them. asserted
Gustafson → be → them
mRNA vaccines having a moment It's been a big year for cancer vaccines using mRNA, especially after drugmakers Merck and Moderna released results last month from the first major successful trial of mRNA vaccines for skin cancer, showing a 42% reduction in recurrence and death over two years. asserted
Merck → have → years
A combination of technologies using mRNA, genomics and AI, helped create these vaccines, which are also being tested on lung, kidney, bladder and brain cancers. asserted
which → use → cancers
But researchers don't yet understand why some trials have failed, while others show eye-popping results in the form of people like Gustafson. asserted
others → understand → Gustafson
Gustafson, who splits her time between New Jersey and Florida, says she wasn't scared to be first to test this concept against pancreatic cancer. asserted
she → split → cancer
She credits her three grown daughters for finding and getting her into the trial. asserted
She → credit → trial
"It was a no brainer," she says. asserted
she → say → ?
"I knew that statistically, the odds of my survival were low, and I was very happy to be offered some type of hope." asserted
I → know → hope
Gustafson received nine doses of the vaccine, along with surgery and chemotherapy. asserted
Gustafson → receive → surgery
She was part of a small clinical trial involving 16 pancreatic cancer patients. asserted
She → involve → patients
The vaccine worked on half of the patients, and seven of those eight are still alive today. asserted
seven → work → eight
It does not compare to chemotherapy, which requires hours of infusion and comes with after-effects that were "barbaric" for his wife, Ed Gustafson says with a shudder. asserted
Gustafson → compare → shudder
By contrast: The shots felt like nothing, Donna Gustafson says. asserted
Gustafson → feel → nothing
"I had no symptoms, no side effects — to the point where I was actually worried that maybe it was not helping. asserted
it → have → point
Surgeon and scientist Vinod Balachandran ran the trial at Memorial Sloan Kettering Cancer Center in New York City. asserted
Balachandran → run → City
The vaccine used in his research is made in an expansive lab made up of hallways of freezers, desks, centrifuges and cytometers. asserted
vaccine → use → freezers
Patients' responses to the treatment are measured in the lab. asserted
responses → measure → lab
The oncologists and mathematicians who work there are dedicated to decoding pancreatic cancer, then reverse engineering the mRNA necessary to fight it. asserted
who → work → it
A research analyst pulls up a graph on her computer, showing dozens of superimposed green lines — each representing the number of times an immune cell reproduces, Balachandran explains. asserted
Balachandran → pull → times
Looking at the graph representing Donna Gustafson's immune cell count, Balachandran notes how the lines shoot up, then remain high and flat — "a 10,000-fold increase" — reflecting how her immune system mass produced cancer-attacking cells and sustained it, for years beyond her last shot. asserted
system → look → shot
"It just tells us that this response lasts," Balachandran says. asserted
Balachandran → tell → us
Balachandran says it was the strength and durability of such responses in half of the patients that, for him, blew open the possibility of mRNA vaccines. asserted
that → say → vaccines
"Well, if you could generate such a strong immune response in the toughest of cancers, could this similarly develop cancer vaccines for a broad array of human cancers?," he says. uncertain
he → generate → cancers
The National Cancer Institute, for example, is working on a partnership with private companies to fast-track research and development of more mRNA cancer vaccines. asserted
Institute → work → vaccines
Balachandran and Sloan Kettering are part of that, with plans to expand production of personalized vaccines for patients on site. asserted
Kettering → expand → site
Donna Gustafson says she and her husband have felt overwhelmingly lucky over the past seven years. asserted
she → say → years
"I saw two more grandchildren be born and grow, many birthdays, holidays and Christmases with my family," she says. asserted
she → see → family
With her husband, she's created and ticked off many items off her bucket list: skydiving, summiting, celebrating their 50th anniversary with the expectation of many more to come. asserted
she → create → more
"We've done so many things — we probably have done so much more," Ed Gustafson says, before his wife picks up his sentence, "...if we had not had this experience." asserted
we → do → experience
"We live so much more for the day now," Ed Gustafson says, looking at his wife. asserted
Gustafson → live → wife
💬Give feedback
🕘History 🎫Support